How to Profit from AI Cures: The Revolutionary Potential of CRISPR Therapeutics

Alexander Green, Chief Investment Strategist

Log In

Enter your username and password below

Published in September, 2025

Editorial Note: From time to time, The Oxford Club will discuss investment ideas that will not be included in the Club’s various portfolios. There are certain situations where we feel a company may be an extraordinary value but may not necessarily fit within the selection guidelines of these existing portfolios. In these cases, the recommendations are to be considered speculative and should not be considered part of any of the Club’s portfolios.

Also, by the time you receive this report, there is a chance that we may have exited a recommendation previously included in one of our portfolios. Occasionally this happens because we use a disciplined “trailing stop” philosophy with the majority of our investments, meaning that anytime a company’s share price falls 25% from its high, we sell the stock. For the most up-to-date look at what is included in our tracked portfolios, visit https://oxfordclub.com.

Legal Note: Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.

Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201

How to Profit from AI Cures: The Revolutionary Potential of CRISPR Therapeutics

Newsletters

Trading Services